News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.

Latest News

June 13, 2024

Nivolumab Fails to Benefit Esophageal Cancer Treatment in EA2174 Trial: Dr Jennifer Eads

June 13, 2024

Dr Eads on Nivolumab Plus Neoadjuvant Chemoradiation in Esophageal/GEJ Cancer

June 13, 2024

Personalizing Chemotherapy for Black Women

June 13, 2024

EAZ171 Trial Suggests Black Patients With Breast Cancer Have Lower Risk of Taxane-Induced Peripheral Neuropathy With Docetaxel Than Paclitaxel

June 13, 2024

Study Suggests Docetaxel is Superior for Neuropathy in Black Patients With Breast Cancer

June 13, 2024

EA highlights at ASCO in OncoDaily

June 3, 2024

Press Release: ECOG-ACRIN completes first trial of Black patients with early-stage breast cancer

May 22, 2024

Press Release: TMIST breast cancer screening trial enrollment surpasses 100,000

May 16, 2024

CompassHER2 pCR trial to evaluate the HER2DX® score

May 15, 2024

Press Release: ECOG-ACRIN announces the recipients of its 2024 scientific leadership and mentorship awards

May 14, 2024

ECOG-ACRIN research at ASCO 2024

May 14, 2024

Coming soon: EA7222 for patients with advanced soft tissue sarcoma

May 14, 2024

myeloMATCH, the next revolution in the NCI’s National Clinical Trials Network

May 14, 2024

Increasing inclusion and equity for Black women in breast cancer clinical trials (mentions EAZ171)

May 14, 2024

NCCN recommends universal testing for MSI and dMMR for all newly diagnosed gastric cancer patients

May 8, 2024

Press Release: ECOG-ACRIN adds another trial to the ComboMATCH precision oncology study platform

May 1, 2024

Jefferson Health earns Comprehensive Cancer Center designation from NCI

May 1, 2024

The May News from ECOG-ACRIN blog is now available

April 24, 2024

Press Release: ECOG-ACRIN research at ASCO 2024

April 15, 2024

Boston Gene announces participation in ComboMATCH

ECOG-ACRIN Cancer Research Group